Free Trial

Erasca (ERAS) Financials

Erasca logo
$1.23 +0.13 (+11.45%)
As of 11:06 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Erasca

Annual Income Statements for Erasca

This table shows Erasca's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-162 -125 -243
Consolidated Net Income / (Loss)
-162 -125 -243
Net Income / (Loss) Continuing Operations
-162 -125 -243
Total Pre-Tax Income
-162 -125 -243
Total Operating Income
-180 -142 -247
Total Gross Profit
0.00 0.00 0.00
Total Revenue
0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
180 142 247
Selling, General & Admin Expense
42 38 33
Research & Development Expense
138 104 214
Other Operating Expenses / (Income)
0.00 0.00 0.00
Total Other Income / (Expense), net
18 16 4.65
Interest & Investment Income
20 17 4.90
Other Income / (Expense), net
-2.16 -0.23 -0.26
Basic Earnings per Share
($0.69) ($0.83) ($1.99)
Weighted Average Basic Shares Outstanding
233.82M 150.18M 122.02M
Diluted Earnings per Share
($0.69) ($0.83) ($1.99)
Weighted Average Diluted Shares Outstanding
233.82M 150.18M 122.02M
Weighted Average Basic & Diluted Shares Outstanding
283.27M 151.49M 150.59M
Cash Dividends to Common per Share
$0.00 $0.00 $0.00

Quarterly Income Statements for Erasca

This table shows Erasca's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-32 -31 -63 -35 -30 -30 -32 -33 -135 -35
Consolidated Net Income / (Loss)
-32 -31 -63 -35 -30 -30 -32 -33 -135 -35
Net Income / (Loss) Continuing Operations
-32 -31 -63 -35 -30 -30 -32 -33 -135 -35
Total Pre-Tax Income
-32 -31 -63 -35 -30 -30 -32 -33 -135 -35
Total Operating Income
-36 -37 -68 -39 -34 -35 -36 -37 -138 -37
Total Operating Expenses
36 37 68 39 34 35 36 37 138 37
Selling, General & Admin Expense
9.59 9.61 12 10 9.07 9.45 9.75 9.44 8.72 8.78
Research & Development Expense
26 28 56 29 25 25 26 28 129 28
Total Other Income / (Expense), net
3.48 6.04 4.58 3.83 4.17 4.30 4.19 3.83 2.83 1.47
Interest & Investment Income
5.28 5.87 5.04 3.90 4.24 4.35 4.25 3.88 2.88 1.52
Other Income / (Expense), net
-1.80 0.17 -0.46 -0.07 -0.07 -0.05 -0.06 -0.05 -0.05 -0.05
Basic Earnings per Share
($0.06) ($0.11) ($0.29) ($0.23) ($0.20) ($0.20) ($0.21) ($0.22) ($1.09) ($0.29)
Weighted Average Basic Shares Outstanding
233.82M 282.38M 217.81M 151.16M 150.18M 150.45M 150.04M 149.50M 122.02M 120.80M
Diluted Earnings per Share
($0.06) ($0.11) ($0.29) ($0.23) ($0.20) ($0.20) ($0.21) ($0.22) ($1.09) ($0.29)
Weighted Average Diluted Shares Outstanding
233.82M 282.38M 217.81M 151.16M 150.18M 150.45M 150.04M 149.50M 122.02M 120.80M
Weighted Average Basic & Diluted Shares Outstanding
283.27M 282.73M 282.50M 173.36M 151.49M 151.09M 151.04M 150.76M 150.59M 122.36M

Annual Cash Flow Statements for Erasca

This table details how cash moves in and out of Erasca's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents
-25 -191 -76
Net Cash From Operating Activities
-109 -101 -103
Net Cash From Continuing Operating Activities
-109 -101 -103
Net Income / (Loss) Continuing Operations
-162 -125 -243
Consolidated Net Income / (Loss)
-162 -125 -243
Depreciation Expense
3.81 3.73 2.64
Amortization Expense
-9.59 -6.95 -0.99
Non-Cash Adjustments To Reconcile Net Income
56 30 122
Changes in Operating Assets and Liabilities, net
1.74 -3.19 16
Net Cash From Investing Activities
-157 -91 -71
Net Cash From Continuing Investing Activities
-157 -91 -71
Purchase of Property, Plant & Equipment
-0.06 -1.78 -15
Acquisitions
-23 -20 -2.00
Purchase of Investments
-403 -314 -134
Sale and/or Maturity of Investments
269 245 80
Other Investing Activities, net
-0.16 0.00 -
Net Cash From Financing Activities
241 1.30 98
Net Cash From Continuing Financing Activities
241 1.30 98
Issuance of Common Equity
240 0.79 96
Other Financing Activities, net
0.84 0.51 2.00
Cash Income Taxes Paid
0.00 0.00 0.00

Quarterly Cash Flow Statements for Erasca

This table details how cash moves in and out of Erasca's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-1.15 -104 96 -16 -20 -26 -134 -11 65 -79
Net Cash From Operating Activities
-25 -22 -29 -33 -25 -24 -26 -26 -26 -24
Net Cash From Continuing Operating Activities
-25 -22 -29 -33 -25 -24 -26 -26 -26 -24
Net Income / (Loss) Continuing Operations
-32 -31 -63 -35 -30 -30 -32 -33 -135 -35
Consolidated Net Income / (Loss)
-32 -31 -63 -35 -30 -30 -32 -33 -135 -35
Depreciation Expense
0.83 0.84 1.13 1.00 0.94 0.94 0.96 0.89 0.93 0.77
Amortization Expense
-2.35 -2.52 -2.38 -2.34 -2.20 -2.37 -1.41 -0.98 -0.83 -0.17
Non-Cash Adjustments To Reconcile Net Income
8.06 6.64 35 6.85 10 6.24 7.01 6.85 105 -2.08
Changes in Operating Assets and Liabilities, net
1.13 3.82 0.53 -3.74 -3.97 1.43 -0.73 0.08 3.39 13
Net Cash From Investing Activities
23 -103 -87 9.97 4.55 -1.81 -109 15 -4.87 -55
Net Cash From Continuing Investing Activities
23 -103 -87 9.97 4.55 -1.81 -109 15 -4.87 -55
Purchase of Investments
-67 -192 -100 -44 -61 -54 -175 -24 -38 -74
Sale and/or Maturity of Investments
90 89 36 54 66 52 67 60 34 19
Net Cash From Financing Activities
0.80 21 212 6.93 0.46 0.01 0.65 0.18 96 0.43
Net Cash From Continuing Financing Activities
0.80 21 212 6.93 0.46 0.01 0.65 0.18 96 0.43
Issuance of Common Equity
0.41 21 212 6.91 0.26 - 0.53 0.00 95 -
Other Financing Activities, net
0.40 0.31 0.11 0.02 0.19 0.01 0.12 0.18 0.74 0.43

Annual Balance Sheets for Erasca

This table presents Erasca's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
503 395 515
Total Current Assets
309 321 444
Cash & Equivalents
68 93 284
Short-Term Investments
231 219 151
Prepaid Expenses
10 8.33 8.88
Plant, Property, & Equipment, net
16 22 25
Total Noncurrent Assets
177 52 46
Long-Term Investments
142 9.64 0.00
Other Noncurrent Operating Assets
35 43 46
Total Liabilities & Shareholders' Equity
503 395 515
Total Liabilities
79 79 103
Total Current Liabilities
31 26 49
Accounts Payable
0.47 2.00 23
Accrued Expenses
26 20 24
Other Current Liabilities
4.62 3.97 1.31
Total Noncurrent Liabilities
48 52 54
Other Noncurrent Operating Liabilities
48 52 54
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
423 317 412
Total Preferred & Common Equity
423 317 412
Preferred Stock
0.00 0.00 0.00
Total Common Equity
423 317 412
Common Stock
1,191 923 894
Retained Earnings
-768 -606 -481
Accumulated Other Comprehensive Income / (Loss)
0.41 0.08 -1.04

Quarterly Balance Sheets for Erasca

This table presents Erasca's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
529 526 370 419 441 468 446
Total Current Assets
330 418 307 306 324 398 366
Cash & Equivalents
69 173 77 113 139 273 219
Short-Term Investments
250 236 221 184 178 117 137
Prepaid Expenses
11 9.59 8.94 9.30 6.61 8.14 9.82
Plant, Property, & Equipment, net
17 18 21 23 24 25 25
Total Noncurrent Assets
182 90 42 90 93 45 56
Long-Term Investments
144 52 0.00 47 48 - 9.57
Other Noncurrent Operating Assets
37 38 42 43 45 45 46
Total Liabilities & Shareholders' Equity
529 526 370 419 441 468 446
Total Liabilities
79 75 82 80 78 81 81
Total Current Liabilities
30 25 30 27 23 26 28
Accounts Payable
2.41 2.14 2.63 3.70 2.63 3.35 4.32
Accrued Expenses
23 18 17 19 17 19 22
Other Current Liabilities
4.45 4.29 11 3.82 3.67 3.12 1.03
Total Noncurrent Liabilities
49 50 51 54 55 56 53
Other Noncurrent Operating Liabilities
49 50 51 54 55 56 53
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
450 451 288 339 363 386 365
Total Preferred & Common Equity
450 451 288 339 363 386 365
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
450 451 288 339 363 386 365
Common Stock
1,184 1,156 930 916 909 901 712
Retained Earnings
-735 -704 -641 -576 -546 -514 -346
Accumulated Other Comprehensive Income / (Loss)
1.83 -0.20 -0.21 -0.58 -0.79 -0.51 -1.38

Annual Metrics And Ratios for Erasca

This table displays calculated financial ratios and metrics derived from Erasca's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
0.00% 0.00% 0.00%
EBITDA Growth
-29.35% 41.08% -101.66%
EBIT Growth
-28.21% 42.77% -101.46%
NOPAT Growth
-26.89% 42.81% -98.15%
Net Income Growth
-29.28% 48.50% -97.78%
EPS Growth
16.87% 58.29% -7.57%
Operating Cash Flow Growth
-8.10% 1.98% -29.73%
Free Cash Flow Firm Growth
2.97% 22.76% -58.54%
Invested Capital Growth
-219.90% 77.67% -774.75%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-2.09% 41.50% -78.01%
EBIT Q/Q Growth
-2.01% 42.36% -76.78%
NOPAT Q/Q Growth
-1.04% 42.41% -76.22%
Net Income Q/Q Growth
-1.59% 45.77% -75.92%
EPS Q/Q Growth
16.87% 51.74% -610.71%
Operating Cash Flow Q/Q Growth
0.20% 1.54% -3.91%
Free Cash Flow Firm Q/Q Growth
1.47% 29.88% 0.00%
Invested Capital Q/Q Growth
-28.00% -15.75% -13,252.25%
Profitability Metrics
- - -
Gross Margin
0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00%
Interest Burden Percent
88.94% 88.21% 98.02%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00%
Return on Equity (ROE)
-43.68% -34.33% -55.92%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-43.68% -34.33% -55.92%
Return on Equity Simple (ROE_SIMPLE)
-38.17% -39.48% -58.95%
Net Operating Profit after Tax (NOPAT)
-126 -99 -173
NOPAT Margin
0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-9.43% -6.86% -15.55%
Return On Investment Capital (ROIC_SIMPLE)
-29.68% -31.28% -
Cost of Revenue to Revenue
0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-182 -142 -248
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-188 -145 -246
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.68 1.02 1.28
Price to Tangible Book Value (P/TBV)
1.68 1.02 1.28
Price to Revenue (P/Rev)
0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00
Financial Leverage
-1.03 -1.04 -1.03
Leverage Ratio
1.21 1.25 1.17
Compound Leverage Factor
1.08 1.10 1.15
Debt to Total Capital
0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00
Altman Z-Score
2.72 0.02 1.10
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
9.84 12.26 9.13
Quick Ratio
9.50 11.94 8.95
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-114 -118 -152
Operating Cash Flow to CapEx
-182,361.67% -5,702.37% -709.67%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00
Capital & Investment Metrics
- - -
Invested Capital
-17 -5.31 -24
Invested Capital Turnover
0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
-12 18 -21
Enterprise Value (EV)
269 -0.18 92
Market Capitalization
710 322 527
Book Value per Share
$1.50 $2.10 $3.37
Tangible Book Value per Share
$1.50 $2.10 $3.37
Total Capital
423 317 412
Total Debt
0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
-440 -322 -436
Capital Expenditures (CapEx)
0.06 1.78 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-21 -18 -40
Debt-free Net Working Capital (DFNWC)
277 295 396
Net Working Capital (NWC)
277 295 396
Net Nonoperating Expense (NNE)
36 26 70
Net Nonoperating Obligations (NNO)
-440 -322 -436
Total Depreciation and Amortization (D&A)
-5.79 -3.22 1.65
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($0.69) ($0.83) ($1.99)
Adjusted Weighted Average Basic Shares Outstanding
233.82M 150.18M 122.02M
Adjusted Diluted Earnings per Share
($0.69) ($0.83) ($1.99)
Adjusted Weighted Average Diluted Shares Outstanding
233.82M 150.18M 122.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
283.27M 151.49M 150.59M
Normalized Net Operating Profit after Tax (NOPAT)
-126 -99 -173
Normalized NOPAT Margin
0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Erasca

This table displays calculated financial ratios and metrics derived from Erasca's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
-10.92% -7.22% -90.44% -8.35% 74.50% 0.76% -2.86% -2.78% -357.16% 20.66%
EBIT Growth
-10.54% -6.81% -89.39% -4.97% 75.43% 6.23% -0.10% -1.38% -352.23% 19.75%
NOPAT Growth
-5.43% -7.46% -88.44% -4.93% 75.47% 6.23% -0.18% -1.42% -344.72% 19.72%
Net Income Growth
-8.52% -2.76% -98.86% -5.48% 78.04% 14.45% 10.75% 8.94% -343.97% 22.97%
EPS Growth
70.00% 45.00% -38.10% -4.55% 81.65% 31.03% 30.00% 29.03% -275.81% 36.96%
Operating Cash Flow Growth
0.90% 7.05% -12.45% -26.15% 6.01% -0.73% 4.38% -2.14% -17.30% -3.13%
Free Cash Flow Firm Growth
68.39% 12.40% -123.75% -7.53% 44.22% 32.35% 50.96% 30.69% 0.00% -2.70%
Invested Capital Growth
-219.90% -189.29% -249.79% -182.03% 77.67% -2,475.28% -161.22% -213.22% -774.75% 95.13%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-0.75% 44.24% -72.59% -14.40% 2.61% 0.96% 1.80% 73.08% -279.03% -2.65%
EBIT Q/Q Growth
-1.20% 45.68% -75.35% -14.67% 2.21% 3.68% 2.82% 73.16% -273.21% -2.82%
NOPAT Q/Q Growth
4.11% 45.06% -74.47% -14.70% 2.27% 3.65% 2.85% 73.19% -273.57% -2.94%
Net Income Q/Q Growth
-3.31% 50.63% -80.49% -17.90% 2.17% 4.47% 4.27% 75.45% -281.10% 0.33%
EPS Q/Q Growth
45.45% 62.07% -26.09% -15.00% 0.00% 4.76% 4.55% 79.82% -275.86% 3.33%
Operating Cash Flow Q/Q Growth
-9.57% 23.18% 12.23% -34.14% -2.77% 7.06% 1.54% 0.05% -10.14% 11.78%
Free Cash Flow Firm Q/Q Growth
23.36% 57.48% -92.87% 49.71% -112.40% -8.60% 7.31% 73.91% -157.60% 21.28%
Invested Capital Q/Q Growth
-28.00% -44.75% 1.24% -74.82% -15.75% -75.03% 20.37% 86.16% -13,252.25% -104.16%
Profitability Metrics
- - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
85.92% 84.17% 92.61% 89.98% 87.51% 87.48% 88.20% 89.54% 97.92% 95.89%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-43.68% -40.33% -38.90% -37.60% -34.33% -65.48% -62.21% -59.07% -55.92% -32.54%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-43.68% -40.33% -38.90% -37.60% -34.33% -65.48% -62.21% -59.07% -55.92% -32.54%
Return on Equity Simple (ROE_SIMPLE)
0.00% -35.36% -35.09% -43.99% 0.00% -68.03% -64.99% -61.99% 0.00% -37.78%
Net Operating Profit after Tax (NOPAT)
-25 -26 -47 -27 -24 -24 -25 -26 -97 -26
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-1.90% -1.27% -3.82% -2.28% -1.58% -1.72% -1.75% -1.79% -8.63% -2.26%
Return On Investment Capital (ROIC_SIMPLE)
-5.90% - - - -7.49% - - - - -
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-38 -37 -68 -39 -34 -35 -36 -37 -138 -37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-39 -39 -69 -40 -35 -36 -36 -37 -138 -36
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.68 1.71 0.91 1.08 1.02 0.88 1.15 1.17 1.28 2.61
Price to Tangible Book Value (P/TBV)
1.68 1.71 0.91 1.08 1.02 0.88 1.15 1.17 1.28 2.61
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.03 -1.02 -1.01 -1.02 -1.04 -1.01 -1.00 -1.00 -1.03 -1.00
Leverage Ratio
1.21 1.20 1.19 1.24 1.25 1.23 1.17 1.16 1.17 1.14
Compound Leverage Factor
1.04 1.01 1.10 1.12 1.09 1.08 1.03 1.04 1.15 1.09
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
3.67 4.37 1.88 0.42 0.92 0.82 2.02 2.51 1.80 6.60
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
9.84 11.00 16.79 10.14 12.26 11.45 13.90 15.59 9.13 13.21
Quick Ratio
9.50 10.62 16.41 9.84 11.94 11.10 13.62 15.27 8.95 12.86
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-13 -17 -41 -21 -42 -20 -18 -20 -76 -29
Operating Cash Flow to CapEx
0.00% -448,380.00% -224,484.62% -79,169.05% -30,229.27% -10,050.00% -10,506.48% -2,185.57% -3,052.31% -1,336.22%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-17 -13 -9.16 -9.28 -5.31 -4.58 -2.62 -3.29 -24 -0.18
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
-12 -8.68 -6.54 -5.99 18 -4.41 -6.90 -6.19 -21 3.48
Enterprise Value (EV)
269 308 -51 14 -0.18 -46 51 64 92 587
Market Capitalization
710 771 409 312 322 298 416 453 527 953
Book Value per Share
$1.50 $1.59 $2.60 $1.90 $2.10 $2.24 $2.41 $2.57 $3.37 $2.99
Tangible Book Value per Share
$1.50 $1.59 $2.60 $1.90 $2.10 $2.24 $2.41 $2.57 $3.37 $2.99
Total Capital
423 450 451 288 317 339 363 386 412 365
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-440 -463 -460 -298 -322 -344 -365 -390 -436 -365
Capital Expenditures (CapEx)
0.00 0.01 0.01 0.04 0.08 0.24 0.25 1.21 0.86 1.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-21 -19 -15 -21 -18 -17 -17 -17 -40 -18
Debt-free Net Working Capital (DFNWC)
277 300 393 276 295 279 301 372 396 338
Net Working Capital (NWC)
277 300 393 276 295 279 301 372 396 338
Net Nonoperating Expense (NNE)
7.23 5.13 16 7.82 5.99 6.10 6.60 7.28 39 9.62
Net Nonoperating Obligations (NNO)
-440 -463 -460 -298 -322 -344 -365 -390 -436 -365
Total Depreciation and Amortization (D&A)
-1.52 -1.68 -1.24 -1.34 -1.25 -1.43 -0.46 -0.08 0.11 0.60
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.06) ($0.11) ($0.29) ($0.23) ($0.20) ($0.20) ($0.21) ($0.22) ($1.09) ($0.29)
Adjusted Weighted Average Basic Shares Outstanding
233.82M 282.38M 217.81M 151.16M 150.18M 150.45M 150.04M 149.50M 122.02M 120.80M
Adjusted Diluted Earnings per Share
($0.06) ($0.11) ($0.29) ($0.23) ($0.20) ($0.20) ($0.21) ($0.22) ($1.09) ($0.29)
Adjusted Weighted Average Diluted Shares Outstanding
233.82M 282.38M 217.81M 151.16M 150.18M 150.45M 150.04M 149.50M 122.02M 120.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
283.27M 282.73M 282.50M 173.36M 151.49M 151.09M 151.04M 150.76M 150.59M 122.36M
Normalized Net Operating Profit after Tax (NOPAT)
-25 -26 -47 -27 -24 -24 -25 -26 -97 -26
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Erasca's Financials

When does Erasca's fiscal year end?

According to the most recent income statement we have on file, Erasca's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Erasca's net income changed over the last 2 years?

Erasca's net income appears to be on a downward trend, with a most recent value of -$161.65 million in 2024, falling from -$242.81 million in 2022. The previous period was -$125.04 million in 2023. Find out what analysts predict for Erasca in the coming months.

What is Erasca's operating income?
Erasca's total operating income in 2024 was -$179.59 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $179.59 million
How has Erasca revenue changed over the last 2 years?

Over the last 2 years, Erasca's total revenue changed from $0.00 in 2022 to $0.00 in 2024, a change of 0.0%.

How much debt does Erasca have?

Erasca's total liabilities were at $79.03 million at the end of 2024, a 0.5% increase from 2023, and a 23.3% decrease since 2022.

How much cash does Erasca have?

In the past 2 years, Erasca's cash and equivalents has ranged from $67.74 million in 2024 to $284.22 million in 2022, and is currently $67.74 million as of their latest financial filing in 2024.

How has Erasca's book value per share changed over the last 2 years?

Over the last 2 years, Erasca's book value per share changed from 3.37 in 2022 to 1.50 in 2024, a change of -55.5%.



This page (NASDAQ:ERAS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners